SCHEDULE 13G

Company

Autolus Therapeutics plc

Filed

July 10, 2018

Accession Number

0001213900-18-008990

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →